Intrepid Potash, Inc. (NYSE: IPI) is a Denver-based producer of potash and Trio (langbeinite, a potassium-magnesium-sulfate fertilizer), along with salt and water by-products and a developing lithium and bromine recovery project at Wendover, Utah. Coverage of the stock is thin, and the two verifiable current analyst price targets point in sharply different directions.
UBS, which has maintained a Sell rating through 2025 and 2026, most recently raised its price target to $29 in August 2026. On the opposite side, Freedom Capital Markets initiated coverage in July 2026 with a Buy rating and a $45 target, reflecting optimism about potash pricing and the company's project optionality. Morgan Stanley has also carried a Sell rating on the shares, though a current published price target could not be verified. Averaging the two attributable targets, $29 and $45, yields a mean of $37, which is the central target used here.
Because the two available targets sit on either side of the stock's trading range, the analyst "consensus" is not a clean signal. Aggregate ratings services label the name Moderate Sell or Sell, yet the wide $29-to-$45 range underscores genuine disagreement about the company's earnings power rather than a uniform, cautious view.
Shares of Intrepid Potash recently traded near $32, giving the company a market capitalization of roughly $430 million. Reaching the $37 central target would require an advance of about 15%, a modest move for a stock whose 52-week range spans $22.55 to $50.34.
The path toward the target would most plausibly run through sustained potash price strength and higher realized selling prices, which flow quickly through to this operationally leveraged, single-commodity business. The company returned to profitability over recent quarters, reporting first-quarter 2026 revenue of roughly $98.7 million and net income near $7.4 million, up from about $94.5 million and $4.6 million a year earlier. With trailing EPS (earnings per share) near $0.91 and a P/E (price-to-earnings) ratio in the mid-30s, however, the market is already pricing in meaningful recovery, which raises the bar for further multiple expansion.
The stock has already demonstrated the volatility needed to reach $37, having surged to a 52-week high of $50.34 in March 2026 before retreating to the low-$30s. The $37 target therefore sits comfortably below that prior peak, suggesting it is not an especially distant level by this stock's own standards. On the downside, the shares have recently consolidated in the $31-to-$32 area, a near-term support zone, with the 52-week low of $22.55 marking a much deeper level. Round-number levels such as $30 and $40 may also act as psychological markers, while the March high stands as the most notable longer-term resistance area above the target.
Analyst price targets typically reflect a research horizon of about 12 months, though the two targets here were issued months apart and reflect different assumptions about the potash cycle. Investors weighing the $37 level should watch quarterly earnings and guidance, reported potash and Trio realized prices, any updates on the Wendover lithium and bromine project, and broader fertilizer and agricultural commodity trends. Analyst revisions matter more than usual for a thinly covered name, because a single target change from UBS, Freedom Capital Markets, or Morgan Stanley can shift the entire published range.
For traders tracking volatile, thinly covered names such as Intrepid Potash, AI Daily Buy/Sell Signals from Tickeron offers a data-driven complement to traditional research. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to spot changing trends, monitor existing positions, and surface new opportunities more efficiently than manual screening allows. Explore how AI-powered signals can support your own decision-making process.
The $37 central target for Intrepid Potash is the average of two genuinely opposed analyst views, a $29 Sell from UBS and a $45 Buy from Freedom Capital Markets, and represents a modest, roughly 15% advance from a recent price near $32. Reaching it would likely require potash prices and realized selling prices to keep firming, validating the more bullish end of the analyst range. The principal obstacles are a rich valuation for a cyclical producer, the risk of potash price declines, and the cautious stance of two major sell-side firms. With coverage so thin and the published range so wide, the $37 figure is best read as a midpoint of genuine disagreement rather than a forecast. Investors should monitor potash pricing, quarterly results, the Wendover project, and any analyst revisions before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, IPI has been closely correlated with CF. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if IPI jumps, then CF could also see price increases.